Yeo Jung Moon

Investment Division Director

40 past transactions

LINER

Series B in 2024
LINER is an innovative company that has developed Asia's first AI Agent, known as the "AI Workspace." This autonomous agent utilizes LLM-based artificial intelligence to perform a variety of complex tasks, significantly enhancing user productivity. LINER's personalized search engine, powered by advanced technologies like GPT-4, allows users to efficiently collect, manage, and derive insights from information, drastically reducing research time from hundreds of minutes to mere seconds. With a user base exceeding 94% from outside Korea and spanning over 100 countries, LINER stands out for its unique highlighter database, which differentiates its offerings in the competitive landscape of productivity tools.

Aimedbio

Series B in 2024
Aimedbio is a healthcare company focused on delivering therapeutic solutions for patients suffering from serious brain diseases. The company specializes in developing therapeutic systems and medications aimed at treating neuro-oncological and degenerative conditions. Aimedbio's mission is to enhance the quality of life for individuals dealing with refractory brain diseases, including various forms of cancer. Through its innovative approaches, the company seeks to address significant unmet medical needs in the field of neurology.

Feature

Seed Round in 2024
Feature is an innovative entertainment studio focused on transforming television into immersive metaverse experiences. By utilizing blockchain and proprietary technologies, the company enhances marketing, engagement, and loyalty among audiences. Feature's patent-pending web3 video stack enables creators to convert passive viewers into identifiable users, thereby fostering a direct connection between creators, brands, and their audiences. The company also provides interactive minting capabilities, blockchain-enabled gaming, and social media integration, allowing for the development of Web3 native content tailored to engage users across new digital platforms.

Mobilint

Series B in 2024
Mobilint specializes in developing artificial intelligence-powered chip technology designed to accelerate deep neural network-based AI algorithms and applications. The company offers integrated solutions through vertical integration of co-optimized algorithms, software, and hardware technologies, enabling clients to achieve enhanced performance, programmability, and end-to-end acceleration for semiconductor services, particularly in the realm of autonomous driving.

Clodot

Venture Round in 2023
Clodot is an information technology company.

OncoResponse

Venture Round in 2023
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.

Wirobotics

Seed Round in 2023
WIRobotics is a developer of innovative wearable robot technology aimed at enhancing musculoskeletal health. The company's products are designed to fit closely to the body, utilizing flexible robotic mechanisms and high-performance actuators. This technology not only reduces physical strain on users but also facilitates active movement. Additionally, WIRobotics incorporates data-driven task monitoring and analysis to quantify labor intensity, providing valuable insights for organizations seeking to improve workplace conditions and promote smart work care. By focusing on the intersection of robotics and health, WIRobotics addresses the physical demands of work environments, ensuring safer and more efficient operations.

Fazz

Series C in 2022
Fazz is a financial technology company based in Singapore and Indonesia, founded in 2016. It focuses on providing digital financial services to enhance financial inclusion across Southeast Asia, particularly targeting underserved segments such as micro and small enterprises. Fazz offers a range of services including payment processing, banking, and investment solutions tailored for small businesses, startups, and large corporations. Its flagship offerings include Fazz Agen, an agent-based financial application designed for micro and small businesses, and Fazz Business, a comprehensive business account that facilitates payments, capital growth, and funding opportunities. The merger of PayFazz and Xfers has strengthened Fazz's position in the fintech landscape, enabling it to deliver diverse financial services to consumers and businesses alike.

Dot

Series B in 2022
Dot Pad — The first tactile graphics display for the visually impaired. (https://www.youtube.com/watch?v=DaxlpMj1sxU) Dot Kiosk - The most accessible kiosk for the disabled and everyone in a smart city.

LinqAlpha

Pre Seed Round in 2022
LinqAlpha is a GenAI-native market intelligence and analytics platform built specifically for hedge funds. Developed by MIT/Harvard PhDs and ex-investment professionals, it automates key aspects of equity research, enabling analysts to efficiently search, analyze, and interpret complex financial data. Already used by several of the top global hedge fund platforms, LinqAlpha enhances decision-making and accelerates research productivity with its finance-specific AI search models.

Ybrain

Private Equity Round in 2022
Ybrain Inc. is a South Korea-based company specializing in the development of wearable devices aimed at addressing neuropsychiatric disorders, including Alzheimer's disease and mild cognitive impairment. Founded in 2013, the company utilizes neuroscience technology to create devices that measure and stimulate brain activity through non-invasive methods, such as transcranial Direct Current Stimulation (tDCS). Ybrain's innovations include a wireless EEG system that allows for efficient collection of brain signals, facilitating targeted treatments for conditions like Major Depressive Disorder. In addition to its device manufacturing, Ybrain is engaged in clinical trials and is developing a big data platform to analyze brain signals, aiming to enhance personalized treatment options for patients.

iN Therapeutics

Series B in 2022
iN Therapeutics is a biotechnology company focused on developing novel therapies for patients with intractable neurological disorders. Its drug development platform concentrates on Nav1.7 non-narcotic analgesics, hearing loss treatments, and brain disease therapeutics, aiming to provide pharmaceutical and biotech industries access to innovative central nervous system disease drugs.

H2O Hospitality

Series C in 2021
H2O Hospitality, Ltd. is a hospitality management company based in Seoul, South Korea, specializing in the Korean and Japanese markets. Established in 2015, it is recognized as the largest vacation rental management company in its region. H2O Hospitality offers a range of services including profit management, housekeeping and facility management, customer call response, online sales and marketing, as well as reservation and inventory management. The company utilizes an innovative property management system (PMS) that automates operational flows by linking calendars between guests, rooms, and housekeepers, thereby significantly reducing fixed operational costs and enhancing facility yield. Additionally, H2O Hospitality provides digital management solutions to streamline operations for vacation rental properties, facilitating bookings from various online travel agencies and optimizing customer attraction.

Mobilint

Series A in 2021
Mobilint specializes in developing artificial intelligence-powered chip technology designed to accelerate deep neural network-based AI algorithms and applications. The company offers integrated solutions through vertical integration of co-optimized algorithms, software, and hardware technologies, enabling clients to achieve enhanced performance, programmability, and end-to-end acceleration for semiconductor services, particularly in the realm of autonomous driving.

Publy

Series B in 2021
Publy is a content platform tailored for working individuals, focusing on providing subscription services for curated content. The platform allows users to create, design, archive, store, and publish custom content and events. By facilitating the purchase and reservation of content from various media sources, Publy empowers users to access and utilize both current and forthcoming materials. This innovative approach aims to enhance the way professionals engage with and manage content in their work environments.

ABLY

Series B in 2021
Ably Corporation is a fashion platform that facilitates a marketplace where customers can sell products to one another. The platform features a forum that allows influencers and celebrities to create online stores, showcasing and selling products directly. This enables consumers to stay informed about the latest fashion trends and purchase clothing similar to that worn by their favorite public figures. Through its application, Ably aims to enhance the shopping experience by connecting users with trendy apparel and fostering a community around fashion.

Catch Table

Series B in 2021
Catch Table is a restaurant reservation management platform that offers a streamlined solution for booking tables in various dining establishments. It enables customers to make real-time reservations while filtering options based on specific criteria, including date, number of guests, price range, food category, and table type. Additionally, the platform provides useful information about amenities like valet parking and corkage services, enhancing the overall dining experience. By facilitating these features, Catch Table aims to simplify the reservation process for customers and improve operational efficiency for restaurants.

My Chef

Series B in 2021
My Chef sells home meal kits.

Gridwiz

Series C in 2021
Gridwiz is an energy company that specializes in delivering efficient and sustainable energy services to its clients. The company focuses on power demand management, helping users optimize their energy consumption. Additionally, Gridwiz manufactures and sells electric vehicle charging modems and chargers, supporting the growing demand for electric mobility. The company is also involved in the installation and operational management of energy storage systems (ESS) and solar power generation facilities, contributing to the transition towards renewable energy sources. Through its diverse offerings, Gridwiz aims to enhance energy efficiency and promote environmentally friendly practices in the energy sector.

DoctorHere

Series A in 2020
DoctorHere is a smart medical clinic using AI and IT to provide primary care both in-person and virtually

Evidnet

Series A in 2020
EvidNet is a healthcare IT company focused on providing Real World Evidence (RWE) solutions that leverage hospital data to enhance research and decision-making in the life sciences and healthcare sectors. The company collaborates with over 50 university and tertiary hospitals in Korea to generate Real World Data (RWD) using the OMOP-CDM standard. Its FeederNet® data platform facilitates multi-institutional research and allows for AI-driven federated machine learning, ensuring privacy and security are maintained. EvidNet's platform is designed to support precision and predictive medicine by creating an interoperable, real-time healthcare data network. This network offers tailored statistical analysis to meet the specific needs of hospitals and healthcare providers, enabling easier access to vital health information for both professionals and patients.

Riiid

Series D in 2020
Riiid is a global innovator in AI-powered education solutions, specializing in adaptive assessment platforms that personalize learning experiences for students worldwide. Launched in 2017 with Santa TOEIC, its flagship product has reached over one million users in Korea alone, demonstrating proven efficacy. Expanding globally, Riiid operates Santa TOEIC in Japan and offers Santa SAT in Vietnam. Its scalable AI technology provides each student with a personalized tutor, enhancing learning outcomes while reducing costs compared to traditional methods. By democratizing educational opportunities, Riiid is rapidly transforming the learning landscape.

FamePick

Series A in 2019
FamePick Inc. is a subscription-based internet platform founded in 2016 and headquartered in Sunnyvale, California. The company focuses on the advertising and marketing industry by enabling users to find, secure, and launch celebrity-driven marketing campaigns across social media. FamePick provides seasoned creators and influencers with essential tools to manage their personal brands effectively. The platform offers automated media kits that include audience reach, detailed demographics, and recent brand deals, helping creators assess their market value. Additionally, FamePick facilitates connections between established creators and like-minded partners, supporting them in building stronger relationships and expanding their reach into other platforms and paid media.

Aerodyne

Series B in 2019
Aerodyne Group is a global leader in drone-based enterprise solutions, specializing in DT3 technologies (Drone Tech, Data Tech, Digital Transformation). With over 1000 drone professionals, they have managed more than 560,000 infrastructure assets across 32 countries, conducting over 458,000 flight operations. Aerodyne offers large-scale data operations and analytics for industries like power infrastructure inspection, wind turbines, and solar farms, optimizing processes and increasing productivity. Recognized globally for its innovations, the company has been awarded Frost & Sullivan's 'Asia Pacific UAV Services Company of 2019' and IET Malaysia's 'Industry Excellence Gold Award 2019'. Its founder and Group CEO, Kamarul A Muhamed, is a recipient of prestigious awards such as EY's Entrepreneur of the Year 2020.

Finda

Series A in 2019
Finda, Inc. is a data-driven online comparison platform based in Seoul, South Korea, specializing in various financial products such as mortgages, personal loans, and investments. The company enables users to compare different financial offerings by collecting and analyzing data from multiple industries, including the automobile finance sector. Finda's platform not only helps users identify suitable financial products but also provides economic calculation services related to housing loans, monthly savings, and loan repayment. By focusing on delivering customized financial information, Finda aims to empower individuals to make informed financial decisions in a timely manner.

Sualab

Series C in 2019
Sualab is a company focused on developing artificial intelligence-based solutions aimed at enhancing industrial efficiency through automation. By leveraging advanced image analysis technology, Sualab's smart factory system automates tasks traditionally performed by humans, specifically in sectors such as textiles, leather, and steel. This innovative approach allows for unmanned automatic inspection and process optimization, enabling companies to monitor and control essential variables to maintain optimal production conditions. Sualab's mission is to increase the value of human time by automating repetitive tasks, thereby facilitating a more efficient and effective industrial landscape.

Orum Therapeutics

Series B in 2019
Orum Therapeutics, Inc. is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of a novel class of therapeutic antibodies through its proprietary cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's approach enables the intracellular delivery of active antibody therapeutics or payloads, allowing it to inhibit drug targets that are typically considered undruggable by existing small molecules or antibody treatments. The technology is adaptable, capable of targeting various cell types and intracellular proteins without the need for chemical modifications. By merging the precision of antibodies with the efficacy of protein degraders, Orum aims to facilitate the development of new medicines that can effectively treat patients with challenging health conditions.

Medi Plus Solution

Series A in 2019
MediPlus Solution is a digital healthcare service provider that focuses on delivering personalized rehabilitation services. One of its key offerings is the Second Doctor program, which caters specifically to patients recovering from stomach, colorectal, breast, or prostate cancer. This comprehensive program includes exercise regimens, nutrition management, medication oversight, and educational resources to enhance patients' recovery and overall quality of life. Additionally, MediPlus Solution offers a bidirectional medical support system for chronic patients, facilitating real-time communication between physicians, patients, and caregivers. This system enables effective health information sharing and medical guidance, ultimately aiming to improve patient outcomes through tailored activity monitoring and disease management services.

Publy

Series B in 2019
Publy is a content platform tailored for working individuals, focusing on providing subscription services for curated content. The platform allows users to create, design, archive, store, and publish custom content and events. By facilitating the purchase and reservation of content from various media sources, Publy empowers users to access and utilize both current and forthcoming materials. This innovative approach aims to enhance the way professionals engage with and manage content in their work environments.

Intelon Optics

Series A in 2018
Intelon Optics, Inc. is a bio-mechanical diagnostic and surgical device company based in Lexington, Massachusetts, with a manufacturing center in Rochester, New York. Established in 2015, the company specializes in the development and commercialization of innovative eye diagnostic optical solutions. Its flagship product, the Brillouin Optical Scanner System, is an advanced optical-scanning platform designed to identify the intrinsic biomechanical properties of both transparent and opaque ocular tissues, including the cornea, sclera, and lens. This technology facilitates next-generation point-by-point biomechanical imaging of eye structures, enabling eye care professionals to enhance their diagnostic and surgical capabilities for treating various eye diseases.

Sparkplus

Series A in 2018
SparkPlus is a South Korean company founded in 2016 that specializes in designing and managing real estate contracts, interior design, construction, and furniture arrangements for office spaces. The company operates coworking spaces aimed at businesses facing challenges with their office environments. By providing comprehensive solutions to corporate office issues, SparkPlus enables clients to focus on their core activities without the distractions of managing office-related problems. The firm's services are tailored to create functional and efficient workspaces that enhance productivity and business growth.

ExoCoBio

Series B in 2018
ExoCoBio Inc. is a South Korean company founded in 2017 that specializes in the development of biopharmaceuticals and cosmeceuticals derived from stem cell-derived exosomes. These nano-vesicles play a crucial role in intercellular signaling, facilitating skin and tissue regeneration. ExoCoBio focuses on creating innovative therapeutics and cosmetic products aimed at enhancing health and promoting regeneration, particularly in skin and hair. By leveraging the unique properties of exosomes, the company aims to provide effective alternatives in regenerative medicine and improve overall well-being.

Caxe

Series C in 2018
Caxe Technologies is a provider of financial services technology that caters to blue-chip B2B clients. The company specializes in developing a data and AI-based platform that delivers a range of digitized financial services, including digital banking software, credit decision tools, analytics, risk management solutions, and regulatory reporting. Through its innovative platform, Caxe enables clients to access various products and services that facilitate informed decision-making in the financial sector.

Neuraly

Series A in 2018
Neuraly, Inc. is a clinical-stage biotechnology company based in Germantown, Maryland, focused on developing innovative treatments for neurodegenerative diseases, including Parkinson's and Alzheimer's diseases. Founded in 2016, the company emerged from research led by prominent neuroscientists and has secured exclusive licenses for key patents related to its drug candidates. Neuraly is advancing several compounds, notably NLY01, a neuroprotective agent designed to inhibit pathological microglial activation, and NLY02 and NLY03, which are blood-brain barrier-penetrating kinase inhibitors. The company's approach aims to address the underlying mechanisms of neurodegeneration by targeting glial cell activity and preventing neuronal cell death, with the ultimate goal of improving the quality of life for patients affected by these debilitating conditions.

JLK

Venture Round in 2018
JLK, Inc. is a South Korean company specializing in artificial intelligence-driven medical and security solutions. It develops advanced AI platforms that support diagnosis and treatment by providing real-time, on-site services integrated with hospital systems. JLK focuses on a range of medical conditions, offering solutions for brain diseases such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease, as well as lung diseases, coronary artery disease, and prostate cancer. The company also emphasizes digital pathology and data analysis in its offerings. Formerly known as JLK INSPECTION Co., Ltd., JLK, Inc. is headquartered in Cheongju, South Korea.

Dot

Venture Round in 2018
Dot Pad — The first tactile graphics display for the visually impaired. (https://www.youtube.com/watch?v=DaxlpMj1sxU) Dot Kiosk - The most accessible kiosk for the disabled and everyone in a smart city.

Orum Therapeutics

Series A in 2017
Orum Therapeutics, Inc. is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of a novel class of therapeutic antibodies through its proprietary cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's approach enables the intracellular delivery of active antibody therapeutics or payloads, allowing it to inhibit drug targets that are typically considered undruggable by existing small molecules or antibody treatments. The technology is adaptable, capable of targeting various cell types and intracellular proteins without the need for chemical modifications. By merging the precision of antibodies with the efficacy of protein degraders, Orum aims to facilitate the development of new medicines that can effectively treat patients with challenging health conditions.

ImmunoMet Therapeutics

Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, dedicated to developing and commercializing innovative oncology drugs. Founded in 2015, the company focuses on improving the quality of life for cancer patients through its advanced pipeline of products. This includes metabolic regulators designed to target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors aimed at anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet Therapeutics is positioned to make significant contributions to the field of oncology.

The Pinkfong Company

Series A in 2015
The Pinkfong Company is a global entertainment firm that specializes in creating and distributing engaging content for audiences worldwide. Renowned for its award-winning brands and intellectual properties, the company offers a diverse range of entertainment experiences, including original animated series, live tours, and interactive games. By focusing on the dual goals of enjoyment and education, The Pinkfong Company aims to inspire and connect people of all ages, fostering joyful experiences and learning opportunities through its innovative content.

IGAWorks

Series C in 2014
IGAWorks is a full-stack ad-tech company established in 2006, specializing in supporting digital marketing and mobile businesses. The company offers a comprehensive suite of services that includes Tradingworks, a media and audience trade desk; adbrix, an all-in-one data platform for mobile growth based on advertising and user performance; and adPOPcorn, Korea’s largest advertising network. Additionally, IGAWorks provides Mobile Index, a mobile app market analytics platform, and Campaign Intelligence, a reporting tool that streamlines marketers' reporting processes. With its integrated mobile platform, IGAWorks enables publishers to monetize their applications effectively by offering analytics, mobile attribution, marketing automation, and market intelligence solutions. Currently, over 30,000 mobile applications utilize IGAWorks' offerings to enhance their business growth.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.